Home / Letter From The Editor / Oct. 13, 2020

Oct. 13, 2020

Oct 13, 2020

This week we offer you part 3 of our series on the use of AI to select a proper diabetes medication regimen. Your response to the information has been overwhelming, and if the comments we have received are an indication of the desire to have this tool available, it only seems like a matter of time till the GlucosePATH software is available for everyone.

One feature that was commented on is the ability of the software to address comorbidities in selecting medication. This is very important when we look at patient disease states and multiple uses for a single medication.


This week Destiny Funchess, PharmD Candidate, South College School of Pharmacy, has a great article on how the use of a very common diabetes medication can possibly have an effect on reducing the risk of dementia.



We can make a difference!


Dave Joffe